Compounds > guanidine

guanidine and ribavirin

guanidine has been researched along with ribavirin in 6 studies

Research

Studies (6)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	2 (33.33)	29.6817
2010's	3 (50.00)	24.3611
2020's	1 (16.67)	2.80

Authors

Authors	Studies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Bisaillon, M; Bougie, I	1
Agudo, R; Domingo, E; Manrubia, SC; Perales, C; Tejero, H	1
Agudo, R; Domingo, E; Manrubia, SC; Perales, C	1
Domingo, E; Iranzo, J; Manrubia, SC; Perales, C	1
Honkimaa, A; Hyöty, H; Sioofy-Khojine, AB	1

Reviews

1 review(s) available for guanidine and ribavirin

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Other Studies

5 other study(ies) available for guanidine and ribavirin

Article	Year
Initial binding of the broad spectrum antiviral nucleoside ribavirin to the hepatitis C virus RNA polymerase. The Journal of biological chemistry, 2003, Dec-26, Volume: 278, Issue:52 Topics: Adenosine Triphosphate; Binding Sites; Binding, Competitive; Catalysis; Circular Dichroism; DNA-Directed RNA Polymerases; Dose-Response Relationship, Drug; Electrophoresis, Polyacrylamide Gel; Guanidine; Hepacivirus; Interferon-alpha; Ions; Kinetics; Ligands; Nucleotides; Phosphorylation; Protein Binding; Ribavirin; Spectrometry, Fluorescence; Spectrophotometry; Thermodynamics; Time Factors	2003
Potential benefits of sequential inhibitor-mutagen treatments of RNA virus infections. PLoS pathogens, 2009, Volume: 5, Issue:11 Topics: Animals; Antiviral Agents; Cell Line; Cricetinae; Evolution, Molecular; Foot-and-Mouth Disease Virus; Guanidine; Models, Biological; Mutagens; Mutation; Ribavirin; RNA, Viral; Virus Replication	2009
Influence of mutagenesis and viral load on the sustained low-level replication of an RNA virus. Journal of molecular biology, 2011, Mar-18, Volume: 407, Issue:1 Topics: Animals; Antiviral Agents; Blotting, Western; Foot-and-Mouth Disease; Foot-and-Mouth Disease Virus; Guanidine; Mutagenesis; Mutagens; Mutation; Reverse Transcriptase Polymerase Chain Reaction; Ribavirin; RNA, Messenger; RNA, Viral; Viral Load; Virus Replication	2011
Tempo and mode of inhibitor-mutagen antiviral therapies: a multidisciplinary approach. Proceedings of the National Academy of Sciences of the United States of America, 2011, Sep-20, Volume: 108, Issue:38 Topics: Algorithms; Animals; Antiviral Agents; Cell Line; Dose-Response Relationship, Drug; Drug Resistance, Viral; Foot-and-Mouth Disease Virus; Guanidine; Models, Biological; Mutagens; Mutation; Ribavirin; Time Factors; Virus Replication	2011
A preclinical assessment to repurpose drugs to target type 1 diabetes-associated type B coxsackieviruses. Diabetic medicine : a journal of the British Diabetic Association, 2020, Volume: 37, Issue:11 Topics: A549 Cells; Amides; Antiviral Agents; Azithromycin; Benzimidazoles; Coxsackievirus Infections; Diabetes Mellitus, Type 1; Drug Repositioning; Enterovirus B, Human; Fluoxetine; Guanidine; Humans; Immunoglobulin G; Lovastatin; Oxadiazoles; Oxazoles; Oximes; Pyrazines; Ribavirin; Sulfonamides	2020